Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Phase 2 Study to Investigate the Efficacy and Safety of Zelicapavir in Participants Aged ≥28 Days to ≤36 Months of Age Infected With Respiratory Syncytial Virus

Zelicapavir is a novel, orally administered, nonfusion replication inhibitor of RSV. It is being investigated in this Phase 2 study (EDP 938-203) as a potential treatment for RSV infection in both hospitalized and non-hospitalized children aged ≥28 days to ≤36 months who present with symptomatic RSV infection.

Participants needed: 150
Trial details
Phase: Phase 2Age: 28-36Biological sex: AllType: InterventionalSponsor: Enanta Pharmaceuticals, IncUpdated: Jul 20, 2026Locations: 8
Eligibility criteria

Participants diagnosed with RSV infection using an approved diagnostic assay, wi... [+2]

Participant has any condition that in the opinion of the Investigator would inte... [+4]

Read more
Status: Recruiting

A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Doses of EDP-978 in Healthy Adults

This study is a randomized, double-blind, sponsor-open, placebo-controlled study. It will assess the safety, tolerability, pharmacokinetics and pharmacodynamics of orally administered single and multiple doses of EDP-978 in healthy adult subjects.

Participants needed: 98
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Enanta Pharmaceuticals, IncUpdated: Apr 21, 2026Locations: 1
Eligibility criteria

An informed consent document signed and dated by the subject. [+1]

Clinically relevant evidence or history of illness or disease. [+8]

Read more